$38.40
arrow_drop_down4.78%Key Stats | |
---|---|
Open | $40.13 |
Prev. Close | $40.33 |
EPS | -6.35 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 39.65 | 40.55 |
52 Week Range | 13.36 | 41.30 |
Ratios | |
---|---|
EPS | -6.35 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Why AnaptysBio Was Such a Healthy Stock This Week
Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
Repligen (RGEN) Soars 4.4%: Is Further Upside Left in the Stock?
The Analyst Landscape: 7 Takes On AnaptysBio
AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates
Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update